We identified that anti-PD-1 plus anti-PD-L1 treatment of mice bearing orthotopic tumors improved mouse survival and induced systemic expansion of tumor-specific T cells that were then recruited to the TME and further differentiated into central and tissue resident memory T cells following orthotopic tumor clearance (23). The gene discussed is RPL17; the disease is neoplasm.